CAPSAICIN FORTE CREAM 0.075 % — DIN 02150123
CAPSAICIN : 0.075 % · WEX PHARMACEUTICALS INC · CREAM · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is CAPSAICIN FORTE CREAM?
CAPSAICIN FORTE CREAM 0.075 % contains CAPSAICIN : 0.075 %. It is listed in the Health Canada Drug Product Database under DIN 02150123, held by WEX PHARMACEUTICALS INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Aug-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Capsaicin And Similar Agents cost around the world?
Capsaicin And Similar Agents is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory); Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 4 | 7 | USD███.██ |
| Greece | producer price (ex-factory) | 6 | 6 | EUR███.██ |
| Bahrain | retail (max) | 1 | 2 | BHD███.██ |
| Iceland | max wholesale | 2 | 2 | ISK███.██ |
| Norway | max AUP (pharmacy retail) | 1 | 1 | NOK███.██ |
18 pack listings across 14 brand entries and 5 price bases, refreshed 07 Sep 2026. Ranges span every Capsaicin And Similar Agents pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Capsaicin And Similar Agents in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Capsaicin And Similar Agents, across 19 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| WEX PHARMACEUTICALS INC | 3 | 0 | CAPSAICIN FORTE CREAM, CAPSAICIN MILD CREAM, CAPSAICIN REGULAR CREAM | No marketed DIN |
| THE MENTHOLATUM COMPANY OF CANADA LTD | 2 | 0 | MENTHACIN - CREAM, MENTHACIN LOTION | No marketed DIN |
| ALVIN LAST, INC. | 1 | 0 | BORN AGAIN SUPER PAIN RELIEVING LOTION | No marketed DIN |
| BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 1 | 0 | FINALGON ONT | No marketed DIN |
| CORPORATION EMUOL | 1 | 0 | FLEX-OL | No marketed DIN |
| DEL PHARMACEUTICS (CANADA) INC. | 1 | 0 | ARTHRICARE FOR WOMEN MULTI-ACTION | No marketed DIN |
| FERNDALE LABORATORIES INC. | 1 | 0 | CAPSAICIN CREAM 0.025% | No marketed DIN |
| GOLDEN MOOR | 1 | 0 | MOOR BALM - CRM | No marketed DIN |
| HERBALIFE INTERNATIONAL OF AMERICA, INC. | 1 | 0 | SUPER ARTHRITIS PAIN RELIEF | No marketed DIN |
| ODAN LABORATORIES LTD | 1 | 0 | CAPSODAN CREAM | No marketed DIN |
| STELLA PHARMACEUTICAL CANADA INC. | 1 | 0 | CAPZASIN-P CREME - 0.025% | No marketed DIN |
| VIVIER MEDICAL INC. | 1 | 0 | RUB A535 CAPSAICIN | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.075 % |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Capsaicin And Similar Agents |
|---|---|
| ATC code | M02AB |
| AHFS class | 84:24.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02150123 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2150123 |
| Brand name | CAPSAICIN FORTE CREAM |
| Generic / active ingredient | CAPSAICIN : 0.075 % |
| Market authorization holder | WEX PHARMACEUTICALS INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AB |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M02AB |
| Current status | CANCELLED POST MARKET |
| Status date | 31-Aug-2009 |
| Original market date | 1995-03-06 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 19 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTHRICARE FOR WOMEN MULTI-ACTION | 1.25 % | CREAM | DEL PHARMACEUTICS (CANADA) INC. | CANCELLED POST MARKET | 01935046 |
| BENEJOINT | 0.025 % | CREAM | LANE LABS-USA, INC. | CANCELLED POST MARKET | 02239488 |
| BIOBALSAM | 0.75 % | CREAM | BIOPHARMATECH INC. | CANCELLED POST MARKET | 02230695 |
| BORN AGAIN SUPER PAIN RELIEVING LOTION | 0.025 % | LOTION | ALVIN LAST, INC. | CANCELLED POST MARKET | 02236788 |
| CAPSAICIN CREAM 0.025% | .025 % | CREAM | FERNDALE LABORATORIES INC. | CANCELLED POST MARKET | 02185717 |
| CAPSAICIN MILD CREAM | 0.025 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | 02150107 |
| CAPSAICIN REGULAR CREAM | 0.05 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | 02150115 |
| CAPSODAN CREAM | 4 % | CREAM | ODAN LABORATORIES LTD | CANCELLED PRE MARKET | 02231073 |
| CAPZASIN-P CREME - 0.025% | .025 % | CREAM | STELLA PHARMACEUTICAL CANADA INC. | CANCELLED POST MARKET | 02174308 |
| FINALGON ONT | 2.5 % | OINTMENT | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | 00067423 |
2 · Same class — other molecules in ATC M02AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Capsaicin And Similar Agents | ARTHRICARE FOR WOMEN MULTI-ACTION · BENEJOINT · BIOBALSAM · BORN AGAIN SUPER PAIN RELIEVING LOTION · +15 more | 19 | 0 | Not in Canada |
| Capsaicin | ANTIPHLOGISTINE RUB A-535 CAPSAICIN GEL · ANTIPHLOGISTINE RUB A-535 CAPSAICIN LIQUID · ARTHRICARE FOR WOMEN EXTRA MOISTURIZING · ARTHRICARE FOR WOMEN QUICK DRYING · +2 more | 6 | 0 | Not in Canada |
| Zucapsaicin | ZUACTA | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M02AC | Preparations With Salicylic Acid Derivatives | 120 | 11 |
| M02AA | Bufexamac · Diclofenac | 16 | 8 |
| M02AX | Dimethyl Sulfoxide · Various | 60 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CAPSAICIN FORTE CREAM called?
Also recorded in Canada as: capsaicin 0.08 MG/MG Medicated Patch [Qutenza] (US), capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel [Capzasin Quick Relief] (US), capsaicin 0.00025 MG/MG Medicated Patch [WellPatch] (US), capsaicin 0.25 MG/ML / menthol 10 MG/ML / methyl salicylate 120 MG/ML Topical Cream [ZIKS Pain Relief] (US), capsaicin 0.25 MG/ML / methylnicotinate 5 MG/ML Topical Lotion [Arth-RX] (US), capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Medicated Patch [Medrox] (US), capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin] (US), capsaicin 0.375 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin] (US), capsaicin 0.02 MG/ML / menthol 100 MG/ML / methyl salicylate 200 MG/ML Topical Lotion [Xoten-C] (US), capsaicin 0.0005 MG/MG / menthol 0.07 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox] (US), capsaicin 0.25 MG/ML / trolamine salicylate 100 MG/ML Topical Cream [Arthur Itis] (US), capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Transanosil] (US), capsaicin 0.35 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm] (US), capsaicin 0.00025 MG/MG Topical Gel [Equi-Block Original] (US), capsaicin 0.25 MG/ML / menthol 20 MG/ML Topical Cream [Zostrix Joint & Arthritis Pain Relief] (US).
The same molecule, Capsaicin And Similar Agents, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Qutenza | Latin | Bahrain, Iceland, Norway |
| Capsina | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.